In vivo molecular imaging of atherosclerotic lesions in ApoE-/- mice using VCAM-1-specific, 99mTc-labeled peptidic sequences

Journal of Nuclear Medicine

Volumn 54, Issue 8, 2013, Pages 1442-1449

  Dimastromatteo, Julien ^a,b   Broisat, Alexis ^a,b   Perret, Pascale ^a,b   Ahmadi, Mitra ^a,b   Boturyn, Didier ^b,c   Dumy, Pascal ^b,c   Fagret, Daniel ^a,b   Riou, Laurent M ^a,b   Ghezzi, Catherine ^a,b  

^a INSERM   (France)

^b UNIV GRENOBLE ALPES   (France)

^c CNRS   (France)

Author keywords

Molecular imaging; VCAM 1; Vulnerable atherosclerotic plaque

Indexed keywords

APOLIPOPROTEIN E; B2702P TC 99M; B2702P1 TC 99M; B2702P10 TC 99M; B2702P11 TC 99M; B2702P12 TC 99M; B2702P13 TC 99M; B2702P14 TC 99M; B2702P15 TC 99M; B2702P16 TC 99M; B2702P17 TC 99M; B2702P18 TC 99M; B2702P19 TC 99M; B2702P2 TC 99M; B2702P20 TC 99M; B2702P3 TC 99M; B2702P4 TC 99M; B2702P5 TC 99M; B2702P6 TC 99M; B2702P7 TC 99M; B2702P8 TC 99M; B2702P9 TC 99M; TECHNETIUM 99M; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANISOTROPY; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY; CAROTID ARTERY LIGATION; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG PURITY; DRUG STABILITY; FLUORESCENCE POLARIZATION; HISTOPATHOLOGY; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; MOLECULAR IMAGING; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION;

MOLECULAR IMAGING; VCAM-1; VULNERABLE ATHEROSCLEROTIC PLAQUE;

AMINO ACID SEQUENCE; ANIMALS; APOLIPOPROTEINS E; FEMALE; KINETICS; MICE; MOLECULAR IMAGING; PEPTIDE FRAGMENTS; PLAQUE, ATHEROSCLEROTIC; TECHNETIUM; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84881461680     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.112.115675     Document Type: Article

References (26)

1. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics: 2011 update-a report from the American Heart Association. Circulation. 2011;123:e18-e209.
2. Naghavi M, Falk E, Hecht HS, et al. From vulnerable plaque to vulnerable patient-part III: executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report. Am J Cardiol. 2006;98: 2H-15H.
3. Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies-part II. Circulation. 2003;108:1772-1778.
4. Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies-part I. Circulation. 2003;108:1664-1672.
5. Sadeghi MM, Glover DK, Lanza GM, Fayad ZA, Johnson LL. Imaging atherosclerosis and vulnerable plaque. J Nucl Med. 2010;51(suppl 1):51S-65S.
6. Riou LM, Broisat A, Dimastromatteo J, Pons G, Fagret D, Ghezzi C. Pre-clinical and clinical evaluation of nuclear tracers for the molecular imaging of vulnerable atherosclerosis: an overview. Curr Med Chem. 2009;16:1499-1511.
7. Iiyama K, Hajra L, Iiyama M, et al. Pattern of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. Circ Res. 1999;85: 199-207.
8. Ley K, Huo Y. VCAM-1 is critical in atherosclerosis. J Clin Invest. 2001;107: 1209-1210.
9. Cybulsky MI, Liyama K, Li H, et al. A major role for VCAM-1 but not ICAM-1, in early atherosclerosis. J Clin Invest. 2001;107:1255-1262.
10. O'Brien KD, Allen MD, McDonald TO, et al. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. J Clin Invest. 1993; 92:945-951.
11. O'Brien KD, McDonald TO, Chait A, Allen MD, Alpers CE. Neovascular expression of E-selectin, intercellular adhesion molecule-1 and vascular adhesion molecule-1 in human atherosclerosis and their relation to intimal leucocyte content. Circulation. 1996;93:672-682.
12. Ramos CL, Huo Y, Jung U, et al. Direct demonstration of P-selectin-and VCAM-1-dependent mononuclear cell rolling in early atherosclerotic lesions of apolipoprotein E-deficient mice. Circ Res. 1999;84:1237-1244.
13. Davies MJ, Gordon JL, Gearing AJ, et al. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J Pathol. 1993;171:223-229.
14. Orr AW, Hastings NE, Blackman BR, Wamhoff BR. Complex regulation and function of the inflammatory smooth muscle cell phenotype in atherosclerosis. J Vasc Res. 2010;47:168-180.
15. Broisat A, Riou LM, Ardisson V, et al. Molecular imaging of vascular cell adhesion molecule-1 expression in experimental atherosclerotic plaques with radiolabelled B2702-p. Eur J Nucl Med Mol Imaging. 2007;34:830-840.
16. Ling X, Tamaki T, Xiao Y, et al. An immunosuppressive and anti-inflammatory HLA class I derived peptides binds vascular cell adhesion molecule-1. Transplantation. 2000;70:662-667.
17. Quartara L, Ricci R, Meini S, et al. Ala scan analogues of HOE 140: synthesis and biological activities. Eur J Med Chem. 2000;35:1001-1010.
18. Marrakchi N, Mabrouk K, Regaya I, et al. Lebetin peptides: potent platelet aggregation inhibitors. Haemostasis. 2001;31:207-210.
19. Van Craenenbroeck M, Gregoire F, De Neef P, Robberecht P, Perret J. Ala-scan of ghrelin (1-14): interaction with the recombinant human ghrelin receptor. Peptides. 2004;25:959-965.
20. Sörme P, Kahl-Knutsson B, Huflejt M, Nilsson UJ, Leffler H. Fluorescence polarization as an analytical tool to evaluate galectin-ligand interactions. Anal Biochem. 2004;334:36-47.
21. Broisat A, Toczek J, Mesnier N, et al. Assessing low levels of mechanical stress in aortic atherosclerotic lesions from apolipoprotein E2/2 mice. Arterioscler Thromb Vasc Biol. 2011;31:1007-1010.
22. Schäfers M, Riemann B, Kopka K, et al. Scintigraphic imaging of matrix metalloproteinase activity in the arterial wall in vivo. Circulation. 2004;109:2554-2559.
23. Kelly KA, Allport JR, Tsourkas A, Shinde-Patil VR, Josephson L, Weissleder R. Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle. Circ Res. 2005;96:327-336.
24. Nahrendorf M, Jaffer FA, Kelly KA, et al. Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation. 2006;114:1504-1511.
25. Nahrendorf M,Keliher E, Panizzi P, et al. 18F-4V for PET-CT imaging of VCAM-1 expression in inflammatory atherosclerosis. JACC Cardiovasc Imaging. 2009;2:1213-1222.
26. Burtea C, Laurent S, Port M, et al. Magnetic resonance molecular imaging of vascular cell adhesion molecule-1 expression in inflammatory lesions using a peptide-vectorized paramagnetic imaging probe. J Med Chem. 2009;52:4725-4742.